Cannabichromene (CBC) is one of the many cannabinoids found in cannabis, and research suggests it has analgesic, antidepressant, antimicrobial, anti-inflammatory, anti-proliferative, and anti-anxiety effects while also having the ability to stimulate bone and brain cell birth. When combined with the cannabinoid CBD, CBC can enhance pain relief. CBC promotes neurogenesis, or brain cell birth, which is not only an important process for memory and learning, but also for preventing the decline of growth in the cells, something that is thought to contribute to disorders like depression and Alzheimer's disease. In addition, CBC interacts with CB1 receptors to release chemicals that reduce anxiety and stress levels.
Cannabichromene reduces inflammation without interacting with cannabinoid receptors. One study has shown CBC reduces gastrointestinal inflammation within mice, making it a potential provider of therapeutic relief Crohn's disease and other inflammatory bowel diseases. The cannabinoid also has antibacterial and antifungal properties, having the ability to combat E. coli and staph infections. Lastly, CBC also inhibits the uptake of anandamide, which is a human-produced endocannabinoid that has anti-cancer benefits. This allows it to remain in the body's system so that it can combat cancer.
This information has been brought to you by Medical Marijuana Inc. and approved by our Chief Medical Officer.